Transfer of a functional human immune system to mice with severe combined immunodeficiency.

Nature
D E MosierD B Wilson

Abstract

The pressing need for a better experimental system for AIDS research has brought into sharp focus the shortcomings of available animal models and the practical and ethical limitations of studies of immune responses and viral pathogenesis in humans. Current studies of the human immune responses are limited to relatively restrictive in vivo experiments and several in vitro systems that, although useful, allow only short-term studies and support responses to a few antigens. Neither model is particularly amenable to studies of the pathogenesis of diseases of the immune system. We report here that injection of human peripheral blood leukocytes (PBL) can result in the stable long-term reconstitution of a functional human immune system in mice with severe combined immunodeficiency (SCID). Human PBL transplanted to SCID mice increase in number and survive for at least six months; reconstituted mice show spontaneous secretion of human immunoglobulin and a specific human antibody response is induced following immunization with tetanus toxoid. All of the major cell populations present in PBL are found in the lymphoid tissue and blood of SCID recipients, although the relative proportions of B cells, T-cell subsets and monocytes/macrophages...Continue Reading

Citations

May 16, 1997·International Journal of Cancer. Journal International Du Cancer·M R AbediC I Smith
Nov 10, 2000·International Journal of Cancer. Journal International Du Cancer·G MulthoffW Hiddemann
Jul 1, 1991·The American Journal of Anatomy·L D Shultz
Oct 1, 1996·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·I E JamesM Gowen
Jan 1, 1993·Journal of Clinical Laboratory Analysis·R I FoxH I Kang
Jan 1, 1997·Stem Cells·M HavengaH H van Es
Jun 9, 1998·Stem Cells·D L GreinerL D Shultz
Oct 1, 1991·Cancer Metastasis Reviews·B M Mueller, R A Reisfeld
Sep 1, 1992·Journal of Clinical Immunology·T S Barry, B F Haynes
Apr 1, 1995·Journal of Biomedical Science·F.Y.T. TungJ.B. Hendricks
Sep 7, 2002·International Journal of Hematology·Jun-ichi MiyagiYuetsu Tanaka
May 31, 2003·International Journal of Hematology·Kazunori Imada
Jun 10, 2010·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Airi HaruiMichael D Roth
Jan 10, 2012·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Santhi GorantlaLarisa Y Poluektova
Jan 20, 2009·Current HIV/AIDS Reports·Paul W Denton, J Victor Garcia
Aug 30, 2008·Immunologic Research·Derek HolmesLishan Su
Nov 22, 2013·International Journal of Hematology·Fumihiko Ishikawa
Feb 1, 1993·International Journal for Parasitology·A H Fell, P M Preston
Mar 21, 1991·Journal of Immunological Methods·S Froidevaux, F Loor
Aug 1, 1994·Journal of Immunological Methods·J M Moore, T V Rajan
Jan 1, 1990·Life Sciences·N EndeN M Ponzio
Nov 1, 1992·Veterinary Immunology and Immunopathology·H J BoermansB A Croy

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.